FDA delay on biosimilars Is a safety ... - HFI Connect - Hep...

HFI Connect - Hepatitis

967 members•1,215 posts

FDA delay on biosimilars Is a safety risk for patients

8 years ago•0 Replies

Fellow PBSA member Lawrence LaMotte stresses the importance for Congress to use their oversight and ensure the FDA publishes guidance on #biosimilars issues essential to patient safety today in The Hill.

bit.ly/1SvhVfe

Written by

HFIAdmin

To view profiles and participate in discussions please or .

Not what you're looking for?

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.